Oral administration of cannabidiol by humans typically results in bioavailability levels of 6.5-20 per cent.
The authors of a new paper say CBD shows “promising anti-inflammatory effects” in Covid-19.
A pilot study was carried out in young people with treatment-resistant anxiety.
The world-first trial has shown promise for the use of CBD gel in focal epilepsy
The findings build on existing evidence that orally-ingested CBD is safe and non-toxic.
According to the authors of a new study, CBD contributed to “extending lifespan”
A recent case report highlights the “unexpected” success of CBD in managing hyperhidrosis.
Studies will examine the effects of THCV, CBN, CBG, and CBC on energy, focus, appetite, sleep disturbance, pain, stress, and anxiety.
Studies show PEA may act in a similar way to CBD by interacting with our endocannabinoid system
The findings address misconceptions that CBD needs to be consumed in high doses to be effective
